Less‑intensive therapy in newly diagnosed acute myeloid leuekmia (AML) in India: Real-world adoption and prognostic utility of ELN‑LI and ELN‑2022 classification
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Chepsy Philip, Uday Kulkarni, Smita Kayal, Hasmukh Jain, Alok Shetty, Gaurav Prakash, Priyanka Samal, Sanjeevan Sharma, M. Joseph John, Prasanna Samuel, Sreeraj Vasudevan, Reshma Roshan, Sandeep Nemani, Smitha Saldanha, Rayaz Ahmed, Omprakash Karunamurthy, Abirami A, Esha Kaul, Suvir Singh, Aakash Chozakade, Monisha Harimadhavan, Jina Bhattacharyya, Chandran Nair, Punit Jain, Thejeswar N, Varun Rajan, Manju Sengar, Vikram Mathews
Institutions: Christian Medical College, Vellore, Jawaharlal Institute of Post Graduate Medical Education and Research, Tata Memorial Hospital, Post Graduate Institute of Medical Education and Research, Institute of Medical Sciences and Sum Hospital, Army Hospital Research and Referral, Christian Medical College, Amala Institute of Medical Sciences, Sher-i-Kashmir Institute of Medical Sciences, Shri Siddhivinayak Ganapati Cancer Hospital, Kidwai Memorial Institute of Oncology, Max Super Speciality Hospital, Dayanand Medical College & Hospital, Amrita Institute of Medical Sciences and Research Centre, Malabar Cancer Centre, Nizam's Institute of Medical Sciences
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417007194
Cites:
Cited by:
Related to: